Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000245944 | SCV000307177 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV000245944 | SCV000522830 | benign | not specified | 2016-01-18 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000460923 | SCV000563083 | benign | Developmental and epileptic encephalopathy 94 | 2025-02-04 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000711188 | SCV000841519 | benign | not provided | 2017-08-09 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002311374 | SCV000846690 | benign | Inborn genetic diseases | 2016-04-26 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV000711188 | SCV005297525 | benign | not provided | criteria provided, single submitter | not provided |